TLR8-AGONIST

Patent europeic · EP3854794 · En vigur

Inscripziun en il register

Numer da publicaziun
EP3854794
Numer da la dumonda
EP19862693
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
19-09-2019
Publitgà
28-07-2021
Concedì
27-11-2024
La protecziun finescha il pli tard
18-09-2039
Proxima taxa annuala scadenta
30-09-2027
Classas IPC
C07D 471/04 (2006.01)
C07D 249/08 (2006.01)
A61K 31/519 (2006.01)
A61P 31/12 (2006.01)
Prioritad
CN 201811094969 19.09.2018
Dumonda PCT
PCT/CN2019/106687 19.09.2019
Publicaziun PCT
WO2020/057604 26.03.2020
Lingua da l’annunzia
chinais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 01-10-2026

    Next annual fee due on

    Next annual fee due on
    30.09.2026 → 30.09.2027

    Published in Swissreg on 01.10.2026

  2. 08-10-2025

    Midada

    Published in Swissreg on 08.10.2025

  3. 01-10-2025

    Next annual fee due on

    Next annual fee due on
    30.09.2025 → 30.09.2026

    Published in Swissreg on 01.10.2025

  4. 29-11-2024

    Represchentant inscrit

    Representative
    VALIPAT, c/o BOVARD LTD, Optingenstrasse 16, 3013 Bern

    Published in Swissreg on 29.11.2024

  5. 27-11-2024

    Concedì

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 27.11.2024

Partidas

Inventur

CAI, Zhe

Shanghai 200131, CN

SUN, Fei

Shanghai 200131, CN

DING, Charles Z.

Shanghai 200131, CN

CHEN, Shuhui

Shanghai 200131, CN

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.